News
Relypsa announced that the Food and Drug Administration (FDA) has approved Veltassa (patiromer) for oral suspension, indicated for the treatment of hyperkalemia.
News
Pharmacologic antihypertensive treatment can significantly reduce the risk of cardiovascular events in patients after blood pressure exceeds certain thresholds, but it does not restore cardiovascular disease (CVD) risk to ideal levels, according to new research in the Journal of the American Heart Association.
Case Studies
There have been only a few documented cases of priapism induced by selective serotonin reuptake inhibitors (SSRIs), but other psychiatric drugs like trazodone or antipsychotics have been linked to priapism. A case study in the International Journal of Psychiatry in Medicine outlines a report of a patient who experienced a 96-hour priapism while taking paroxetine.
Case Studies
Patients treated with the obesity drug orlistat should be regularly screened for kidney dysfunction and hyperoxaluria, the authors of a new case study in Diabetes & Metabolism argue, after a male patient experienced oxalate nephropathy due to hyperoxaluria linked to orlistat use.
News
Gilead Sciences announced that the Food and Drug Administration (FDA) has approved Letairis (ambrisentan) in combination with tadalafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1).
Case Studies
A new report in Case Reports in Urology is only the fifth published case of venlafaxine-induced urinary incontinence (UI), this time in a patient with benign prostatic hyperplasia (BPH) that had been stable for about six years.
News
An updated report in MedLink Neurology stated that oral contraceptives are associated with a small but significant increase in ischemic stroke risk, particularly for women who smoke, have hypertension, or a history of migraine headaches.
Case Studies
Hypersensitivity reactions to hydrochlorothiazide (HCTZ) typically have low incidence rates, but a case study in Case Reports in Medicine highlights the first reported case of probable hydrochlorothiazide (HCTZ)-induced myopericarditis to increase awareness of potential HCTZ-induced pericardial inflammation in patients with sulfa allergy.
News
A new report from the Centers for Disease Control and Prevention (CDC) found that one in two men and two in five women have a heart age five or more years older than their actual age based on risk factors.
Case Studies
A new case study in the journal Case Reports in Medicine emphasizes that a broad differential diagnosis for fever should be considered after a patient with an elevated fever and rigidity was eventually diagnosed with neuroleptic malignant syndrome (NMS) linked to use of certain psychiatric medications.